PPARG and atherosclerosis: PPARγ is hyperacetylated in aging [17], and consistently, the metabolic protections of PPARγ deacetylation are exaggerated in aged 2KR mice, such as the inhibition of visceral adiposity [18] and protection against atherosclerosis [19].